Bionime Corporation (TPE:4737)
Taiwan · Delayed Price · Currency is TWD 63.40
-3.60 (-5.37%)
Apr 20, 2026, 1:24 PM CST
Bionime Market Cap
Bionime has a market cap or net worth of 4.51 billion as of April 20, 2026. Its market cap has increased by 15.76% in one year.
Market Cap
4.51B
Enterprise Value
7.09B
Revenue
1.84B
Ranking
n/a
PE Ratio
n/a
Stock Price
63.40
Market Cap Chart
Since September 3, 2009, Bionime's market cap has increased from 2.06B to 4.51B, an increase of 118.47%. That is a compound annual growth rate of 4.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 4.51B | 12.61% |
| Dec 31, 2025 | 4.00B | 1.37% |
| Dec 31, 2024 | 3.95B | -13.19% |
| Dec 29, 2023 | 4.55B | -2.90% |
| Dec 30, 2022 | 4.69B | 2.61% |
| Dec 30, 2021 | 4.57B | 12.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioteque | 8.28B |
| Medeon Biodesign | 8.10B |
| Formosa Optical Technology | 5.95B |
| Pacific Hospital Supply | 5.88B |
| St.Shine Optical | 5.47B |
| SciVision Biotech | 4.74B |
| Maxigen Biotech | 3.74B |
| Nang Kuang Pharmaceutical | 3.59B |